Shakti Narayan has joined Accent Therapeutics as CEO and member of the company’s board of directors. Narayan comes to Lexington, MA-based Accent from Tango Therapeutics, where he was chief business officer for the past two years. His experience also includes positions at Johnson & Johnson Innovation and Nodality. Accent raised $40 million in Series A funding last year to develop small molecule drugs that block RNA-modifying enzymes involved in cancer.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
